{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T09:31:14Z","timestamp":1786354274541,"version":"build-2736575974"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"DOI":"10.1007\/s00417-026-07393-z","type":"journal-article","created":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:49:59Z","timestamp":1786351799000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The efficacy and safety of oral and topical carbonic anhydrase inhibitors for the treatment of macular edema secondary to retinitis pigmentosa: a systematic review and meta-analysis"],"prefix":"10.1007","author":[{"given":"Cece","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dazhuang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Song","family":"Mi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,10]]},"reference":[{"key":"7393_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2024.101244","volume":"100","author":"M Georgiou","year":"2024","unstructured":"Georgiou M, Robson AG, Fujinami K et al (2024) Phenotyping and genotyping inherited retinal diseases: molecular genetics, clinical and imaging features, and therapeutics of macular dystrophies, cone and cone-rod dystrophies, rod-cone dystrophies, Leber congenital amaurosis, and cone dysfunction syndromes. Prog Retin Eye Res 100:101244. https:\/\/doi.org\/10.1016\/j.preteyeres.2024.101244","journal-title":"Prog Retin Eye Res"},{"key":"7393_CR2","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.preteyeres.2018.03.005","volume":"66","author":"SK Verbakel","year":"2018","unstructured":"Verbakel SK, van Huet RAC, Boon CJF et al (2018) Non-syndromic retinitis pigmentosa. Prog Retin Eye Res 66:157\u2013186. https:\/\/doi.org\/10.1016\/j.preteyeres.2018.03.005","journal-title":"Prog Retin Eye Res"},{"issue":"9549","key":"7393_CR3","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/S0140-6736(06)69740-7","volume":"368","author":"DT Hartong","year":"2006","unstructured":"Hartong DT, Berson EL, Dryja TP (2006) Retinitis pigmentosa. Lancet 368(9549):1795\u20131809. https:\/\/doi.org\/10.1016\/S0140-6736(06)69740-7","journal-title":"Lancet"},{"issue":"8","key":"7393_CR4","doi-asserted-by":"publisher","first-page":"7481","DOI":"10.3390\/ijms24087481","volume":"24","author":"XT Nguyen","year":"2023","unstructured":"Nguyen XT, Moekotte L, Plomp AS, Bergen AA, van Genderen MM, Boon CJF (2023) Retinitis Pigmentosa: Current Clinical Management and Emerging Therapies. Int J Mol Sci 24(8):7481 Published 2023 Apr 19. https:\/\/doi.org\/10.3390\/ijms24087481","journal-title":"Int J Mol Sci"},{"issue":"5","key":"7393_CR5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/eye.2014.344","volume":"29","author":"EM Vingolo","year":"2015","unstructured":"Vingolo EM, Valente S, Gerace E, Spadea L, Nebbioso M (2015) Macular hole in retinitis pigmentosa patients: microincision vitrectomy with polydimethylsiloxane as possible treatment. Eye (Lond) 29(5):699\u2013702. https:\/\/doi.org\/10.1038\/eye.2014.344","journal-title":"Eye (Lond)"},{"key":"7393_CR6","first-page":"767","volume":"21","author":"U Kjellstr\u00f6m","year":"2015","unstructured":"Kjellstr\u00f6m U (2015) Reduced macular function in ABCA4 carriers. Mol Vis 21:767\u2013782 Published 2015 Jul 17","journal-title":"Mol Vis"},{"issue":"3","key":"7393_CR7","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1097\/00006982-199705000-00009","volume":"17","author":"S Grover","year":"1997","unstructured":"Grover S, Fishman GA, Fiscella RG, Adelman AE (1997) Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa. Retina 17(3):222\u2013231. https:\/\/doi.org\/10.1097\/00006982-199705000-00009","journal-title":"Retina"},{"key":"7393_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.preteyeres.2021.101029","volume":"89","author":"N Schneider","year":"2022","unstructured":"Schneider N, Sundaresan Y, Gopalakrishnan P et al (2022) Inherited retinal diseases: linking genes, disease-causing variants, and relevant therapeutic modalities. Prog Retin Eye Res 89:101029. https:\/\/doi.org\/10.1016\/j.preteyeres.2021.101029","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"7393_CR9","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.survophthal.2017.09.009","volume":"63","author":"M Bakthavatchalam","year":"2018","unstructured":"Bakthavatchalam M, Lai FHP, Rong SS, Ng DS, Brelen ME (2018) Treatment of cystoid macular edema secondary to retinitis pigmentosa: a systematic review. Surv Ophthalmol 63(3):329\u2013339. https:\/\/doi.org\/10.1016\/j.survophthal.2017.09.009","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"7393_CR10","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1167\/iovs.14-15995","volume":"56","author":"G Liew","year":"2015","unstructured":"Liew G, Moore AT, Webster AR, Michaelides M (2015) Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa. Invest Ophthalmol Vis Sci 56(3):1531\u20131536. https:\/\/doi.org\/10.1167\/iovs.14-15995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"7393_CR11","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/s0161-6420(81)35040-4","volume":"88","author":"PR Lichter","year":"1981","unstructured":"Lichter PR (1981) Reducing side effects of carbonic anhydrase inhibitors. Ophthalmology 88(3):266\u2013269. https:\/\/doi.org\/10.1016\/s0161-6420(81)35040-4","journal-title":"Ophthalmology"},{"issue":"1","key":"7393_CR12","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2020-000557","volume":"7","author":"CN Schmickl","year":"2020","unstructured":"Schmickl CN, Owens RL, Orr JE, Edwards BA, Malhotra A (2020) Side effects of acetazolamide: a systematic review and meta-analysis assessing overall risk and dose dependence. BMJ Open Respir Res 7(1):e000557. https:\/\/doi.org\/10.1136\/bmjresp-2020-000557","journal-title":"BMJ Open Respir Res"},{"issue":"3","key":"7393_CR13","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3109\/00365598709180326","volume":"21","author":"C Ahlstrand","year":"1987","unstructured":"Ahlstrand C, Tiselius HG (1987) Urine composition and stone formation during treatment with acetazolamide. Scand J Urol Nephrol 21(3):225\u2013228. https:\/\/doi.org\/10.3109\/00365598709180326","journal-title":"Scand J Urol Nephrol"},{"issue":"3","key":"7393_CR14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/s0161-6420(81)35041-6","volume":"88","author":"MA Kass","year":"1981","unstructured":"Kass MA, Kolker AE, Gordon M et al (1981) Acetazolamide and urolithiasis. Ophthalmology 88(3):261\u2013265. https:\/\/doi.org\/10.1016\/s0161-6420(81)35041-6","journal-title":"Ophthalmology"},{"issue":"8","key":"7393_CR15","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1097\/IAE.0b013e31805f6b79","volume":"27","author":"MA Apushkin","year":"2007","unstructured":"Apushkin MA, Fishman GA, Grover S, Janowicz MJ (2007) Rebound of cystoid macular edema with continued use of acetazolamide in patients with retinitis pigmentosa. Retina 27(8):1112\u20131118. https:\/\/doi.org\/10.1097\/IAE.0b013e31805f6b79","journal-title":"Retina"},{"issue":"6","key":"7393_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1136\/bjo.2006.107466","volume":"91","author":"GA Fishman","year":"2007","unstructured":"Fishman GA, Apushkin MA (2007) Continued use of dorzolamide for the treatment of cystoid macular oedema in patients with retinitis pigmentosa. Br J Ophthalmol 91(6):743\u2013745. https:\/\/doi.org\/10.1136\/bjo.2006.107466","journal-title":"Br J Ophthalmol"},{"issue":"9","key":"7393_CR17","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1001\/archophthalmol.2010.172","volume":"128","author":"MA Genead","year":"2010","unstructured":"Genead MA, Fishman GA (2010) Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and usher syndrome. Arch Ophthalmol 128(9):1146\u20131150. https:\/\/doi.org\/10.1001\/archophthalmol.2010.172","journal-title":"Arch Ophthalmol"},{"issue":"5","key":"7393_CR18","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.ajo.2005.12.030","volume":"141","author":"S Grover","year":"2006","unstructured":"Grover S, Apushkin MA, Fishman GA (2006) Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 141(5):850\u2013858. https:\/\/doi.org\/10.1016\/j.ajo.2005.12.030","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"7393_CR19","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1167\/iovs.14-15995","volume":"56","author":"G Liew","year":"2015","unstructured":"Liew G, Moore AT, Webster AR, Michaelides M (2015) Efficacy and prognostic factors of response to carbonic anhydrase inhibitors in management of cystoid macular edema in retinitis pigmentosa. Invest Ophthalmol Vis Sci 56(3):1531\u20131536 Published 2015 Feb 10. https:\/\/doi.org\/10.1167\/iovs.14-15995","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"7393_CR20","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.1167\/iovs.05-0981","volume":"47","author":"K Schulze-Bonsel","year":"2006","unstructured":"Schulze-Bonsel K, Feltgen N, Burau H, Hansen L, Bach M (2006) Visual acuities \u201chand motion\u201d and \u201ccounting fingers\u201d can be quantified with the freiburg visual acuity test. Invest Ophthalmol Vis Sci 47(3):1236\u20131240. https:\/\/doi.org\/10.1167\/iovs.05-0981","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"7393_CR21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","volume":"11","author":"TB Huedo-Medina","year":"2006","unstructured":"Huedo-Medina TB, S\u00e1nchez-Meca J, Mar\u00edn-Mart\u00ednez F, Botella J (2006) Assessing heterogeneity in meta-analysis: Q statistic or I2 index? Psychol Methods 11(2):193\u2013206. https:\/\/doi.org\/10.1037\/1082-989X.11.2.193","journal-title":"Psychol Methods"},{"key":"7393_CR22","first-page":"82","volume":"21","author":"Z Alkin","year":"2013","unstructured":"Alkin Z, \u00d6zkaya A, Karata\u015f G, Yazici AT, Demirok A (2013) Brinzolamide therapy in cystoid macular edema secondary to retinitis pigmentosa. Retina-Vitreus 21:82\u201386","journal-title":"Retina-Vitreus"},{"issue":"8","key":"7393_CR23","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1097\/01.iae.0000250008.83779.23","volume":"26","author":"H Chung","year":"2006","unstructured":"Chung H, Hwang JU, Kim JG, Yoon YH (2006) Optical coherence tomography in the diagnosis and monitoring of cystoid macular edema in patients with retinitis pigmentosa. Retina 26(8):922\u2013927. https:\/\/doi.org\/10.1097\/01.iae.0000250008.83779.23","journal-title":"Retina"},{"issue":"10","key":"7393_CR24","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1001\/archopht.1989.01070020519031","volume":"107","author":"GA Fishman","year":"1989","unstructured":"Fishman GA, Gilbert LD, Fiscella RG, Kimura AE, Jampol LM (1989) Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa. Arch Ophthalmol 107(10):1445\u20131452. https:\/\/doi.org\/10.1001\/archopht.1989.01070020519031","journal-title":"Arch Ophthalmol"},{"issue":"12","key":"7393_CR25","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1001\/archopht.1993.01090120062023","volume":"111","author":"GA Fishman","year":"1993","unstructured":"Fishman GA, Glenn AM, Gilbert LD (1993) Rebound of macular edema with continued use of methazolamide in patients with retinitis pigmentosa. Arch Ophthalmol 111(12):1640\u20131646. https:\/\/doi.org\/10.1001\/archopht.1993.01090120062023","journal-title":"Arch Ophthalmol"},{"issue":"4","key":"7393_CR26","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/s0161-6420(94)31277-2","volume":"101","author":"GA Fishman","year":"1994","unstructured":"Fishman GA, Gilbert LD, Anderson RJ, Marmor MF, Weleber RG, Viana MA (1994) Effect of methazolamide on chronic macular edema in patients with retinitis pigmentosa. Ophthalmology 101(4):687\u2013693. https:\/\/doi.org\/10.1016\/s0161-6420(94)31277-2","journal-title":"Ophthalmology"},{"issue":"6","key":"7393_CR27","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1007\/s00417-011-1904-5","volume":"250","author":"Y Ikeda","year":"2012","unstructured":"Ikeda Y, Hisatomi T, Yoshida N et al (2012) The clinical efficacy of a topical dorzolamide in the management of cystoid macular edema in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol 250(6):809\u2013814. https:\/\/doi.org\/10.1007\/s00417-011-1904-5","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"7393_CR28","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1136\/bjophthalmol-2012-303005","volume":"97","author":"Y Ikeda","year":"2013","unstructured":"Ikeda Y, Yoshida N, Notomi S et al (2013) Therapeutic effect of prolonged treatment with topical dorzolamide for cystoid macular oedema in patients with retinitis pigmentosa. Br J Ophthalmol 97(9):1187\u20131191. https:\/\/doi.org\/10.1136\/bjophthalmol-2012-303005","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"7393_CR29","doi-asserted-by":"publisher","first-page":"377","DOI":"10.3109\/13816810.2015.1101775","volume":"37","author":"MD Lingao","year":"2016","unstructured":"Lingao MD, Ganesh A, Karthikeyan AS et al (2016) Macular cystoid spaces in patients with retinal dystrophy. Ophthalmic Genet 37(4):377\u2013383. https:\/\/doi.org\/10.3109\/13816810.2015.1101775","journal-title":"Ophthalmic Genet"},{"issue":"12","key":"7393_CR30","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s004170050175","volume":"236","author":"B Moldow","year":"1998","unstructured":"Moldow B, Sander B, Larsen M et al (1998) The effect of acetazolamide on passive and active transport of fluorescein across the blood-retina barrier in retinitis pigmentosa complicated by macular oedema. Graefes Arch Clin Exp Ophthalmol 236(12):881\u2013889. https:\/\/doi.org\/10.1007\/s004170050175","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"9","key":"7393_CR31","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1097\/IAE.0000000000003531","volume":"42","author":"JH Yeo","year":"2022","unstructured":"Yeo JH, Min CH, Yoon YH (2022) Effect of oral carbonic anhydrase inhibitor on cystoid macular edema associated with retinitis pigmentosa: an OCT and OCT angiography study. Retina 42(9):1796\u20131804. https:\/\/doi.org\/10.1097\/IAE.0000000000003531","journal-title":"Retina"},{"key":"7393_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.895208","author":"C Chen","year":"2022","unstructured":"Chen C, Liu X, Peng X (2022) Management of Cystoid Macular Edema in Retinitis Pigmentosa: A Systematic Review and Meta-Analysis. Front Med (Lausanne). 9:895208. Published 2022 May 16 https:\/\/doi.org\/10.3389\/fmed.2022.895208","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"7393_CR33","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1097\/IAE.0b013e31809862aa","volume":"28","author":"CA Adackapara","year":"2008","unstructured":"Adackapara CA, Sunness JS, Dibernardo CW, Melia BM, Dagnelie G (2008) Prevalence of cystoid macular edema and stability in oct retinal thickness in eyes with retinitis pigmentosa during a 48-week lutein trial. Retina 28(1):103\u2013110. https:\/\/doi.org\/10.1097\/IAE.0b013e31809862aa","journal-title":"Retina"},{"issue":"4","key":"7393_CR34","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1038\/eye.2008.110","volume":"23","author":"M Hajali","year":"2009","unstructured":"Hajali M, Fishman GA (2009) The prevalence of cystoid macular oedema on optical coherence tomography in retinitis pigmentosa patients without cystic changes on fundus examination. Eye (Lond) 23(4):915\u2013919. https:\/\/doi.org\/10.1038\/eye.2008.110","journal-title":"Eye (Lond)"},{"issue":"1","key":"7393_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1159\/000368052","volume":"233","author":"RF Lemos Reis","year":"2015","unstructured":"Lemos Reis RF, Moreira-Gon\u00e7alves N, Estrela Silva SE, Brand\u00e3o EM, Falc\u00e3o-Reis FM (2015) Comparison of topical dorzolamide and ketorolac treatment for cystoid macular edema in retinitis pigmentosa and Usher\u2019s syndrome. Ophthalmologica 233(1):43\u201350. https:\/\/doi.org\/10.1159\/000368052","journal-title":"Ophthalmologica"},{"issue":"2","key":"7393_CR36","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1097\/IAE.0b013e3181e587f9","volume":"31","author":"A Thobani","year":"2011","unstructured":"Thobani A, Fishman GA (2011) The use of carbonic anhydrase inhibitors in the retreatment of cystic macular lesions in retinitis pigmentosa and X-linked retinoschisis. Retina 31(2):312\u2013315. https:\/\/doi.org\/10.1097\/IAE.0b013e3181e587f9","journal-title":"Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07393-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-026-07393-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-026-07393-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T08:50:00Z","timestamp":1786351800000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-026-07393-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,10]]},"references-count":36,"alternative-id":["7393"],"URL":"https:\/\/doi.org\/10.1007\/s00417-026-07393-z","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,10]]},"assertion":[{"value":"23 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}]}}